Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 18 tags : Therapy save search
Iovance Biotherapeutics to Host Conference Call and Webcast to Highlight Data at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-10-18 (Crawled : 00:00) - biospace.com/
IOVA 4 | $11.69 -1.43% -1.45% 2.7M
|
Health Technology
|
| O: -0.41%
H: 0.38%
C: -3.62%
immunotherapy therapy cancer iot conference
Outlook on the Regenerative Medicine Global Market to 2026 - Focus on Stem Cell Therapy, Biomaterial and Tissue Engineering Among Others
Published: 2021-10-18 (Crawled : 22:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.51%
H: 1.02%
C: 0.19%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.0%
H: 0.23%
C: -0.01%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.82%
H: 0.87%
C: 0.4%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: 0.44%
H: 1.44%
C: 1.35%
BAX | $40.93 -0.22% 0.0% 2.2M
|
Health Technology
|
| O: 0.33%
H: 1.64%
C: 1.58%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.3%
H: 0.29%
C: -0.28%
IART | $29.35 -0.1% -0.1% 900K
|
Health Technology
|
| O: 0.62%
H: 1.84%
C: 0.9%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.67%
H: 1.18%
C: 1.12%
stem cell therapy
Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes
Published: 2021-10-18 (Crawled : 18:00) - biospace.com/
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: 0.4%
H: 0.11%
C: -0.93%
diabetes treatment stem cell phase 1 positive therapy trial
Ultragenyx Initiates Cyprus2+, a Pivotal Clinical Trial Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease
Published: 2021-10-18 (Crawled : 17:00) - biospace.com/
RARE F | $44.26 -1.88% -1.92% 670K
|
Health Technology
|
| O: -1.4%
H: 0.27%
C: -1.09%
disease treatment gene therapy therapy trial
Intra-Cellular Therapies Announces Amended Start Time to Virtual Event on Wednesday, October 20
Published: 2021-10-18 (Crawled : 17:00) - biospace.com/
ITCI 4 d | $73.02 -1.34% -1.36% 730K
|
Health Technology
|
| O: 0.25%
H: 7.08%
C: 5.81%
therapy
Athenex and the Center for Cell and Gene Therapy Announce Allowance of Our First U.S. Patent Claims Around CAR-NKT Cell Therapy
Published: 2021-10-18 (Crawled : 14:00) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: -2.53%
H: 0.74%
C: -2.59%
gene therapy therapy patent
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China
Published: 2021-10-18 (Crawled : 12:00) - prnewswire.com
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
|
| O: -1.19%
H: 4.34%
C: 2.66%
phase 2 china therapy trial approval
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.